Immune Dynamics of Pathological Complete Response to Neoadjuvant Immunotherapy in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Prognostic Implications
Journal of Hepatocellular Carcinoma · 2026-11 · Volume 13 · 1-19
DOI: 10.2147/jhc.s651068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-11. Verfasst von Yunzhi Ling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Chaoyang City Center Hospital of China Medical University, Chaoyang, Liaoning, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Chaoyang City Center Hospital of China Medical University, Chaoyang, Liaoning, People's Republic of China.
ORCID-Profile: Guoming Li, Yantao Fu
Zitieren
APA
Ling, Y., Li, G., Liu, Y., Li, W., & Fu, Y. (2026). Immune Dynamics of Pathological Complete Response to Neoadjuvant Immunotherapy in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Prognostic Implications. Journal of Hepatocellular Carcinoma, Volume 13, 1-19. https://doi.org/10.2147/jhc.s651068
Vancouver
Ling Y, Li G, Liu Y, Li W, Fu Y. Immune Dynamics of Pathological Complete Response to Neoadjuvant Immunotherapy in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Prognostic Implications. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-19. doi:10.2147/jhc.s651068
BibTeX
@article{Ling2026,
author = {Ling, Yunzhi and Li, Guoming and Liu, Yijun and Li, Weijun and Fu, Yantao},
title = {Immune Dynamics of Pathological Complete Response to Neoadjuvant Immunotherapy in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Prognostic Implications},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--19},
doi = {10.2147/jhc.s651068}
}
EUVIMED